GEMSTONE BIOTHERAPEUTICS, LLC

Profile

Company Names

GEMSTONE BIOTHERAPEUTICS, LLC

Addresses

180 W. OSTEND STREET, SUITE 277A, BALTIMORE, MD 21230

810 WYMAN PARK DRIVE, SUITE 400A, BALTIMORE, MD 21211

Phone Numbers

443-873-7010

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

MARYLAND

Total Amount Raised:

$2,300,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2016-10-12 
$700,000.00 
$3,500,000.00 
$2,800,000.00 
Equity 
1
2015-06-04 
$1,600,000.00 
$1,600,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GEORGE 
 
DAVIS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DEMESYS LLC   |  HG EQUILIBRIUM FUND, L.P.   |  AVATECH SOLUTIONS INC   |  GAMMA3, LLC   |  GEMSTONE BIOTHERAPEUTICS, LLC   |  FUSE FINANCIAL TECHNOLOGIES INC.   |  PALLIDUS, INC.   |  PORTER CARES, INC.
SHARON 
 
GERECHT 
DIRECTOR
GEMSTONE BIOTHERAPEUTICS, LLC
XIN 
 
HUANG 
DIRECTOR
GEMSTONE BIOTHERAPEUTICS, LLC   |  CELERO SYSTEMS, INC.   |  BENNUBIO, INC.   |  ZWI THERAPEUTICS, INC.
GEOFF 
 
MACKAY 
DIRECTOR
EGENESIS, INC.   |  REPLICEL LIFE SCIENCES INC.   |  GEMSTONE BIOTHERAPEUTICS, LLC   |  REDACTBIO, INC.   |  TALARIS THERAPEUTICS, INC.   |  SATELLOS BIOSCIENCE INC.
DAVID 
 
OROS 
DIRECTOR, PROMOTER
GLOBAL DOMAIN VECTOR FUND LLC - SERIES A   |  GAMMA3, LLC   |  TERBIUM LABS, LLC   |  GEMSTONE BIOTHERAPEUTICS, LLC   |  TERBIUM LABS, INC.   |  MIND-X CORP.   |  ENEURA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-10-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-12 
2015-06-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#